Nobles Medical Technologies II Receives Significant Japanese Patent for 'Suturing Devices and Methods for Closing a Patent Foramen Ovale' Using Its NobleStitch™ Technology

FOUNTAIN VALLEY, CA.,  Nobles Medical Technologies II (NMT2) today announced that it has received another Patent for the NobleStitch™Technology which provides coverage for its PFO device in Japan. The patent is for "Suturing Devices and Methods for Closing Patent Foramen Ovale (PFO)". This patent provides NMT2 broad coverage of its method and apparatus claims for closing PFO in Japan; PFO closure is the core business of the NMT2 portfolio.

Prof. Anthony Nobles, CEO of NMT2 and co-inventor on the issued patent commented, "Intellectual Property is one of the most valuable assets we have. Particularly on our primary revenue driver the NobleStitch™ EL. In the medical device industry patents represent one of the greatest measurements of the value of a Company. This patent carries broad coverage for specific indication of PFO closure in Japan, which is one of our next target markets."

Ben Brosch, President of NMT2 and co-inventor on the issued patent commented, "We strive to protect our inventions with strong patents that help us maintain a technological advantage. Our shareholders often ask me about our patents -- where are they issued, how long will they be enforceable? This is why we are proud to expand the coverage of our intellectual property around the world and continue to protect our technology for the future. We actively file new patents and continue to grow an extensive portfolio of patents and trademarks adding value to our company and its shareholders."

Rich Babcock, a Director of NMT2, stated, "Patents are a difficult and expensive processes to take from conception through issuance. There is extensive legal and technical expertise required, particularly when filing in foreign countries. Prof. Nobles has successfully authored more than 75 patents in the US and throughout the world. His continued innovation is one of our greatest assets as a technology company and his knowledge of intellectual property is exceptional. NMT2 is committed to continuing to increase its worldwide patent portfolio, and this new issuance is another example of the successful commitment of our team."

Source: Nobles Medical Technologies II, Inc